De Novo closes $250m life science fund
The Menlo Park, California venture capital firm’s second fund will focus on seed and early stage medical technology and biotechnology opportunities.
29 January 2013•1 min read
Infrastructure InvestorThe Menlo Park, California venture capital firm’s second fund will focus on seed and early stage medical technology and biotechnology opportunities.
